This topic contains a solution. Click here to go to the answer

Author Question: The research design to use when strong carry-over effects are thought to be likely is a A) ... (Read 23 times)

APUS57

  • Hero Member
  • *****
  • Posts: 571
The research design to use when strong carry-over effects are thought to be likely is a
 
  A) matched-subjects design.
  B) single-variable, within-subjects design.
  C) class research design.
  D) longitudinal design.

Question 2

In cases in which a treatment has a long-lasting effect on participants, ________ are difficult to control in a within-subjects design.
 
  A) sequence effects
  B) placebo effects
  C) Type I errors
  D) Type II errors
 
  Fill in the blank with the correct answer.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

Mochi

  • Sr. Member
  • ****
  • Posts: 300
Answer to Question 1

Answer: A

Answer to Question 2

Answer: A




APUS57

  • Member
  • Posts: 571
Reply 2 on: Aug 4, 2018
Excellent


tranoy

  • Member
  • Posts: 344
Reply 3 on: Yesterday
Great answer, keep it coming :)

 

Did you know?

Certain rare plants containing cyanide include apricot pits and a type of potato called cassava. Fortunately, only chronic or massive ingestion of any of these plants can lead to serious poisoning.

Did you know?

In Eastern Europe and Russia, interferon is administered intranasally in varied doses for the common cold and influenza. It is claimed that this treatment can lower the risk of infection by as much as 60–70%.

Did you know?

As many as 28% of hospitalized patients requiring mechanical ventilators to help them breathe (for more than 48 hours) will develop ventilator-associated pneumonia. Current therapy involves intravenous antibiotics, but new antibiotics that can be inhaled (and more directly treat the infection) are being developed.

Did you know?

Human stomach acid is strong enough to dissolve small pieces of metal such as razor blades or staples.

Did you know?

For high blood pressure (hypertension), a new class of drug, called a vasopeptidase blocker (inhibitor), has been developed. It decreases blood pressure by simultaneously dilating the peripheral arteries and increasing the body's loss of salt.

For a complete list of videos, visit our video library